Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the recent release of its Nach01 foundation model on Amazon Web Services ...

Biased AI models may lead to results that don’t accurately reflect populations. For example, if a dataset on which a model is ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

For developers and AI practitioners, this question isn’t just hypothetical—it’s a critical challenge. The risks of executing untrusted Python code range from introducing vulnerabilities to ...

Biotech companies are using a new set of artificial intelligence products to hasten drug discovery and other scientific research, and they’re energized by the Food and Drug Administration’s ...

This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.

Peter Diamandis, the entrepreneur behind the XPrize Foundation, has long championed a future of technological promise, building a career on innovation competitions meant to solve grand challenges.